Artificial intelligence, machine learning, and deep learning for clinical outcome prediction
Author(s) -
Rowland W. Pettit,
Robert Fullem,
Chao Cheng,
Christopher I. Amos
Publication year - 2021
Publication title -
emerging topics in life sciences
Language(s) - English
Resource type - Journals
eISSN - 2397-8562
pISSN - 2397-8554
DOI - 10.1042/etls20210246
Subject(s) - artificial intelligence , machine learning , interpretability , generalizability theory , computer science , deep learning , outcome (game theory) , random forest , artificial neural network , software deployment , decision tree , statistics , mathematics , mathematical economics , operating system
AI is a broad concept, grouping initiatives that use a computer to perform tasks that would usually require a human to complete. AI methods are well suited to predict clinical outcomes. In practice, AI methods can be thought of as functions that learn the outcomes accompanying standardized input data to produce accurate outcome predictions when trialed with new data. Current methods for cleaning, creating, accessing, extracting, augmenting, and representing data for training AI clinical prediction models are well defined. The use of AI to predict clinical outcomes is a dynamic and rapidly evolving arena, with new methods and applications emerging. Extraction or accession of electronic health care records and combining these with patient genetic data is an area of present attention, with tremendous potential for future growth. Machine learning approaches, including decision tree methods of Random Forest and XGBoost, and deep learning techniques including deep multi-layer and recurrent neural networks, afford unique capabilities to accurately create predictions from high dimensional, multimodal data. Furthermore, AI methods are increasing our ability to accurately predict clinical outcomes that previously were difficult to model, including time-dependent and multi-class outcomes. Barriers to robust AI-based clinical outcome model deployment include changing AI product development interfaces, the specificity of regulation requirements, and limitations in ensuring model interpretability, generalizability, and adaptability over time.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom